Curious? Tell me what you mean by that

Everyone wants curiosity. Many hiring managers ask for it, and candidates put it on their CVs. But very few can say what it looks like in practice. When I'm helping organisations work out what good looks like in a candidate, I ask them: what do you mean by that word? I ask candidates exactly the same thing when they tell me they're naturally curious. When they pause I realise they don't really…

Qureight publishes in the European Respiratory Journal, calling for fibrosis burden to become the principal structural imaging biomarker for antifibrotic trials

Peer-reviewed Viewpoint ‘Fibrosis extent on HRCT: the principal structural imaging biomarker for antifibrotic trials’ presents argument for measuring both lung function and fibrosis extent in antifibrotic trialsEvaluation of evidence from multiple studies positions fibr

Developing regulated medical device software shouldn't mean choosing between speed and control

We explore how engineering teams can confidently build the technical foundations needed to develop regulated medical device software capable of evolving without losing control of cybersecurity, verification or regulatory evidence.

Rohini Rana joins Salus Wellness Clinics

We are very pleased to announce that Rohini Rana has joined Salus Wellness this month.

Guardtech supporting critical manufacturing equipment segregation with localised Isopod cleanroom enclosures

Rapid-build cleanroom pods providing effective segregation and higher-classified environments around sensitive production equipment for a wide range of engineering and Life Science applications

Curiox Biosystems strengthens commercial leadership to expand adoption of centrifuge-free sample preparation

Curiox Biosystems Inc (Curiox), a provider of centrifuge-free (C-FREE™) sample preparation technologies for reproducible, automated flow cytometry workflows, today announced the expansion of its senior commercial team and the formation of a Strategic Advisory Board (SAB).

Cambridge Design Partnership Strengthens Commercial Leadership

Cambridge Design Partnership welcomes three senior executives to strengthen its commercial leadership, bringing extensive industry experience and expertise to support the company’s next phase of growth.

Panda cubs arrive in Cambridge ahead of citywide charity sculpture trail

Schools and community groups pick up their cubs ahead of the Panda Meander sculpture trail set to hit the streets of Cambridge in March 2027 in aid of Addenbrooke's Charity

The EpiCentre launches Emerging Innovator Programme

One ambitious innovator will receive a 12-month package of support worth more than £25,000, including laboratory space, mentoring and access to a thriving community of innovators.

Silent in one assay, potent in another: VHHs against CDK2/CycE1

A joint Isogenica and Axxam case study profiled 192 VHHs against CDK2/CycE1 in functional assays. It found binders that block the target in two distinct ways, including one that a binding screen alone would have missed.

Atelerix and Frontier Space partner to enable biological sample preservation for space missions

Atelerix, a biotech company revolutionising cell preservation and biological transport with its pioneering hydrogel encapsulation technology, today announced a partnership with Frontier Space, a UK based space biotechnology company building platform technology for in-orbit R&D and biomanufact

First participants join major UK trial to test Alzheimer’s treatments with CPFT

Cambridgeshire and Peterborough NHS Foundation Trust’s (CPFT) research team have helped the very first people take part in a new UK trial to speed up the search for effective Alzheimer’s disease treatments.

BioUK Awards 2026 celebrate outstanding achievement and breakthrough innovations from across the Life Sciences

Abingdon, UK - BioUK, the not-for-profit membership organisation focused on catalysing success in UK life sciences, announces the winners of the 18th annual BioUK Awards following a ceremony hosted at the Royal Lancaster Hotel, London.

Cambridge early-stage companies raise £9bn in a decade as average deal size grows five-fold

New analysis revealed at the Innovate Cambridge Summit shows average equity raised per deal rose fivefold, from £2m in 2015 to £10m in 2025Greater Cambridge led the UK in average life sciences and deep tech investment per deal in 2025, cementing its position as the world’s second mo

Raspberry PI corporate retreat at Barrington Hall

For the fifth consecutive year, Cambridge Dining Co. had the pleasure of delivering a seamless two-day corporate retreat for our valued client, Raspberry PI, hosted at our partner venue, Barrington Hall.

Eppendorf and BioLabs expand collaboration to support biotech innovation in Munich

•    The collaboration will provide laboratory equipment, technical support and engagement opportunities for BioLabs resident companies •    Builds on existing partnerships at BioLabs sites across the US, Germany and France

Takara Bio USA partners with SPT Labtech to deliver automation-ready NGS library preparation technologies

Trusted NGS chemistries from Takara Bio now optimized for firefly® automated workflows

ScionxBio announces collaboration to develop long-acting xRNA Therapeutics

Cambridge, UK, 20 October 2026: ScionxBio (the “company”, operating as a brand identity of Eleven Therapeutics Ltd.

Fashion fundraiser for Addenbrooke’s Charity spotlights secondary breast cancer

Bag a bargain. Inject some joy into your wardrobe. Support a great cause. Do all three at this weekend's Trash Chic charity sale. Taking place in the main mall of Cambridge’s Grand Arcade on Saturday, October 24, the event is being held in aid of Addenbrooke's Charity to support cancer services and help build the new Cambridge Cancer Research Hospital. It will also raise awareness of metastatic…

Qureight appointed imaging CRO for Phase 3 SURPASS-IPF trial as partnership with Celea Therapeutics expands

Celea has now contracted Qureight as the end-to-end imaging CRO for the phase 3 SURPASS-IPF trial, including Fibr8™ and four additional AI imaging models Joint poster at CHEST 2026 presents analysis completed as part of Qureight’s work on Celea’s phase 2b ELEVATE-I

Addenbrooke’s Charitable Trust wins Charity of the Year – and takes home four more awards – at the 2026 National Charity Today Awards

Addenbrooke’s Charitable Trust (ACT) has been crowned Charity of the Year at the 2026 National Charity Today Awards – widely recognised as the ‘Oscars’ of the charitable sector. ACT also topped the Fundraiser of the Year and public-voted People’s Choice Award categories, as well as being highly commended in Volunteer of the Year and PR Team of the Year. With three wins and two runner-up…

What a UK Healthcare Degree Represents

By Lily Lin, CEO, Excellence First Enterprise Consultancy (EFEC)

Expanded international IP protection for concentrated ultra-rapid acting insulins enabling next generation of Automated Insulin Delivery (AID) systems

Arecor Therapeutics plc, a clinical stage biotech company developing superior therapeutics to reduce treatment burden and improve outcomes for people living with diabetes, obesity and other cardiometabolic diseases, has strengthened its patent protection for the company

How do founders handle the people side of scaling? New Cambridge-based project to help scale-up leaders gain insights from peers

Founders and executives at Cambridge scale-ups are being invited to share how they’ve handled the people challenges of fast growth, as part of a new peer insights project.

PHG Foundation to become PHG Cambridge

PHG Foundation is changing its name to PHG Cambridge. The change will be in place from 21 October 2026.What is changingFrom 21 October 2026 you'll start seeing the new name reflected in our website and other communications.